首頁
BlueGenes Lab

8月 2026BlueGenes Lab的市場佔有率分析

SCOTTSDALE, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- BlueGenes, a leading pharmacogenetics (PGX) solution, and Levrx Technology, a digital pharmacy engagement platform, have announced a strategic partnership. Together they aim to accelerate the adoption of personalized prescribing by seamlessly integrating genetic testing insights into pharmacy benefit systems.

行業: N/A

域名bluegeneslab.com

成立年份2021

僱員201 - 500

年度營收--

BlueGenes Lab

BlueGenes Lab（包含公司地區）

bluegeneslab.com

查看更多網站流量與參與度資訊

BlueGenes Lab的熱門網域總造訪量

了解BlueGenes Lab市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

bluegeneslab.com4.3K

透過銷售情報查看更多內容

BlueGenes Lab的熱門網域平均造訪時長

分析BlueGenes Lab參與度指標。

過去 3 個月平均造訪時長

子公司細目

bluegeneslab.com00:00:46

透過銷售情報查看更多內容

BlueGenes Lab的熱門網域平均頁面瀏覽量

了解BlueGenes Lab如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

bluegeneslab.com2.53

透過銷售情報查看更多內容

BlueGenes Lab按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術BlueGenes Lab

这些是BlueGenes Lab顶级域名使用的行业网站技术

付款與貨幣 (9)

Visa

行動裝置 (3)

Meta Viewport

轉換與分析 (2)

Google Analytics

電子郵件服務 (2)

G Suite

更多技術

7

檢視所有

新聞與訊號來自BlueGenes Lab

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Liviniti partnered with Blue Genes Lab, LLC on Aug 1st '26.Liviniti and BlueGenes collaborate for safer, more effective medication management.

新聞Blue Genes, LLC launched precision health platform on May 20th '26.SCOTTSDALE, Ariz., May 20, 2026 (GLOBE NEWSWIRE) - Tru-1 by BlueGenes today announced its official launch, introducing a new precision health platform designed to help healthcare providers, employers, and patients better understand how genetic insights can support personalized treatment and medication decisions.

新聞Blue Genes, LLC partnered with RxSense Group on Feb 23rd '26.SCOTTSDALE, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) - Blue Genes today announced a strategic partnership with RxSense, a leading healthcare technology company delivering innovative pharmacy benefits solutions, to integrate precision medicine insights directly into pharmacy benefit workflows, making pharmacogenomics (PGx) actionable at the point of adjudication.